1-R01-EB031519-01A1 |
Development of 18F PET radiotracers for M2 microglia as diagnostics for multiplesclerosis pathogenesis |
Paul Stupple |
Monash University |
1-R01-EB033919-01A1 |
Bioengineering probiotic bacterium contrast agents for monitoring of inflammation using multispectral optoacoustic tomography |
Jorge Gomez-Gutierrez |
University of Missouri-Columbia |
1-R01-EB034731-01 |
Development of an apoptosis biosensor for monitoring of breast cancer |
Lacey Mcnally |
University of Oklahoma Hlth Sciences Ctr |
1-R01-EB035416-01 |
Two-way Magnetic Resonance Tuning Nanoprobe Enhanced Subtraction Imaging for Precision Diagnosis of Brain Metastasis |
Yuanpei Li |
University of California at Davis |
1-R01-EB035430-01 |
Next-Generation ATP-Independent Luciferases, Luciferins, and Bioluminescent Calcium Indicators |
Huiwang Ai |
University of Virginia |
1-R03-EB035177-01 |
Magnetic resonance imaging methods to track Treg distribution and homing for clinical applications |
Fanny Chapelin |
University of California, San Diego |
1-R13-EB035038-01 |
World Molecular Imaging Congress |
Vladimir Ponomarev |
World Molecular Imaging Society |
1-R13-EB035904-01 |
2024 Metals in Medicine Gordon Research Conference and Gordon Research Seminar |
Carolyn Anderson |
Gordon Research Conferences |
1-R15-EB029559-01 |
Designing Intelligent Iron-Based MRI Contrast Agents |
Joshua Sokoloski |
Salisbury University |
1-R15-EB031528-01 |
Biocompatible Graphene Quantum Dots for Noninvasive Near-infrared Bioimaging |
Anton Naumov |
Texas Christian University |